Coronavirus Update: After FDA Sneaks Out Guidance, Trump’s Vaccine Dream Is Over
Plus Europe Fast Tracks Pfizer/BioNTech Vaccine
Executive Summary
After threats to overrule the agency, the Trump administration has indicated that the stricter guidance will be allowed to stand.
You may also be interested in...
Pfizer’s First COVID-19 Vaccine Results Might Be Just Days Away - But Patience Could Pay Off
Analysts are confident that Pfizer/BioNTech’s mRNA vaccine will prove its safety and efficacy – but waiting a little longer for more robust data could be for the best.
EMA Starts ‘Rolling Review’ Of AstraZeneca’s COVID-19 Vaccine
The European Medicines Agency says its rolling review tool should speed up the evaluation of AstraZeneca’s COVID-19 vaccine.
Coronavirus Update: Gilead's Veklury Gets Full FDA Approval, Roche Partners With Atea
Gilead's remdesivir is first drug fully approved by FDA to treat COVID-19. Roche and Atea team up on an investigational direct acting antiviral while Moderna reaches the 30,000-patient enrollment target for its Phase III COVE study of the company's investigational mRNA vaccine.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports